(XDGU) db x-trackers USD Corporate - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BZ036H21

Corporate, Bonds, Investment Grade, USD, Fixed Income

Description: XDGU db x-trackers USD Corporate

The db x-trackers USD Corporate Bond UCITS DR1D (XETRA:XDGU) is an ETF designed to track the Bloomberg Barclays USD Liquid Investment Grade Corporate Index, providing investors with exposure to a diversified portfolio of USD-denominated corporate bonds issued by financially stable companies.

The underlying index comprises bonds from US and non-US companies across various sectors, including finance, utilities, and industry, with a focus on investment-grade credit ratings, ensuring a relatively low default risk. The bonds in the index are selected based on specific maturity, credit rating, and liquidity criteria, aiming to reflect the performance of the USD corporate bond market.

With an AUM of approximately $650 million (566.63M EUR), the fund offers a decent level of liquidity. As an ETF listed on XETRA, it provides a convenient and transparent way for investors to access the USD corporate bond market.

Analyzing the technical data, we observe that the ETFs last price is $10.90, slightly below its 20-day and 50-day simple moving averages (SMA) of $10.99 and $11.00, respectively. The 200-day SMA stands at $11.53, indicating a potential long-term downtrend. The average true range (ATR) is $0.08, corresponding to a volatility of 0.74%. The 52-week high and low are $12.13 and $10.64, respectively, suggesting a relatively stable price range.

Based on the technical and fundamental analysis, our forecast suggests that the ETF may continue to experience a slight downward pressure in the short term, potentially testing the 52-week low. However, given the investment-grade nature of the underlying bonds and the overall stability of the USD corporate bond market, we expect the ETF to remain relatively resilient. In the medium term, as interest rates stabilize and the global economy recovers, we anticipate a gradual increase in the ETFs price, potentially targeting the 200-day SMA at $11.53.

Additional Sources for XDGU ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

XDGU ETF Overview

Market Cap in USD 667m
Category USD Corporate Bond
TER 0.12%
IPO / Inception 2015-09-30

XDGU ETF Ratings

Growth Rating -16.7
Fundamental -
Dividend Rating 52.9
Rel. Strength -0.61
Analysts -
Fair Price Momentum 12.29 EUR
Fair Price DCF -

XDGU Dividends

Dividend Yield 12m 3.65%
Yield on Cost 5y 3.48%
Annual Growth 5y 3.06%
Payout Consistency 83.1%
Payout Ratio %

XDGU Growth Ratios

Growth Correlation 3m -25%
Growth Correlation 12m -24.7%
Growth Correlation 5y -11.1%
CAGR 5y -1.47%
CAGR/Max DD 5y -0.09
Sharpe Ratio 12m 0.09
Alpha -6.75
Beta -0.046
Volatility 7.14%
Current Volume 4.3k
Average Volume 20d 3k
What is the price of XDGU shares?
As of July 07, 2025, the stock is trading at EUR 10.88 with a total of 4,252 shares traded.
Over the past week, the price has changed by +0.16%, over one month by -1.08%, over three months by -4.56% and over the past year by -2.83%.
Is db x-trackers USD Corporate a good stock to buy?
Neither. Based on ValueRay´s Analyses, db x-trackers USD Corporate is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -16.72 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XDGU is around 12.29 EUR . This means that XDGU is currently undervalued and has a potential upside of +12.96% (Margin of Safety).
Is XDGU a buy, sell or hold?
db x-trackers USD Corporate has no consensus analysts rating.
What are the forecasts for XDGU share price target?
According to our own proprietary Forecast Model, XDGU db x-trackers USD Corporate will be worth about 13.3 in July 2026. The stock is currently trading at 10.88. This means that the stock has a potential upside of +22.06%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 13.3 22.1%